1. Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade
2. Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor
3. Saggar, S.; Sisko, J.; Tucker, T.; Tynebor, R.; Su, D.; Anthony, N. U.S. Patent Appl. US 2,007,021,442, 2007.
4. Zhang, P.; Pennell, M.; Wright, J.; Chen, W.; Leleti, M.; Li, Y.; Li, L.; Xu, Y. PCT Int. Appl. WO 2007002293, Chemocentryx, U.S.A.
5. Chiu, G.; Li, S.; Connolly, P.; Middleton, S.; Emanuel, S.; Huang, S.; Lin, R.; Lu, Y. PCT Int. Appl. WO 2006130673, Janssen Pharmaceutica, N.V., Belgium.